Warning: session_start(): open(/var/cpanel/php/sessions/ea-php80/sess_351218adb38c28f8738e4508325b46ff, O_RDWR) failed: No space left on device (28) in /home/thealthcre/public_html/precedence/classes/cls-connection.php on line 9

Warning: session_start(): Failed to read session data: files (path: /var/cpanel/php/sessions/ea-php80) in /home/thealthcre/public_html/precedence/classes/cls-connection.php on line 9
Biological Therapies Market to Lead USD 1107.66 Bn by 2034
Towards Healthcare
Biological Therapies Market to Lead USD 1107.66 Bn by 2034

Biological Therapies Market 2025 Key Insights with Future Growth

Projections indicate that, biological therapies industry is projected to rise from USD 458.47 billion in 2024 to USD 1107.66 billion by 2034, reflecting a CAGR of 9.35% over the next decade. The biological therapies market is rising due to the rising demand for personalized medicine. North America’s dominance can be attributed to the rising investment in pharma and biotechnology.

  • Insight Code: 6191
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The biological therapies market stands at USD 501.71 billion in 2025 and is expected to reach USD 1107.66 billion by 2034, growing at a CAGR of 9.35% from 2024 to 2034.

North America is currently leading the biological therapies market due to rising demand for gene and cell therapies.

The biological therapies market includes five segments such as by type, by route of administration, by end-users, by distribution channel, and by region.

Some key players include Sanofi, Mayer AG, Lilly, Merck & Co., Inc., Lupin, etc.

Key trends include rising demand for recombinant vaccines and a rise in biologics-based clinical trials.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC, ASPE.